Structures by: Ukrainets I. V.
Total: 26
<i>N</i>-(2,6-Dimethylphenyl)-4-hydroxy-2,2-dioxo-1<i>H</i>-2λ^6^,1-\ benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section C (2020) 76, 1 69-74
a=8.3735(3)Å b=8.3735(3)Å c=20.0299(8)Å
α=90° β=90° γ=120°
<i>N</i>-(2,6-Dimethylphenyl)-4-hydroxy-2,2-dioxo-1<i>H</i>-2λ^6^,1-\ benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section C (2020) 76, 1 69-74
a=8.3729(2)Å b=8.3729(2)Å c=20.0206(6)Å
α=90° β=90° γ=120°
6-Hydroxy-<i>N</i>-(4-methoxyphenyl)-4-oxo-2,4-dihydro-1<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinoline-5-carboxamide
C19H16N2O4
Acta Crystallographica Section C (2018) 74, 12
a=16.3612(6)Å b=8.4646(3)Å c=23.6668(12)Å
α=90° β=108.718(5)° γ=90°
6-Hydroxy-<i>N</i>-(4-methoxyphenyl)-4-oxo-2,4-dihydro-1<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinoline-5-carboxamide
C19H16N2O4
Acta Crystallographica Section C (2018) 74, 12
a=7.1048(19)Å b=10.0882(16)Å c=11.5171(17)Å
α=73.761(17)° β=87.27(2)° γ=76.48(2)°
<i>N</i>-Benzyl-4-hydroxy-1-methyl-2,2-dioxo-1<i>H</i>-2λ6,1-benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section C (2016) 72, 5 411-415
a=5.4764(3)Å b=15.9117(8)Å c=18.3228(10)Å
α=90° β=90° γ=90°
<i>N</i>-Benzyl-4-hydroxy-1-methyl-2,2-dioxo-1<i>H</i>-2λ6,1-benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section C (2016) 72, 5 411-415
a=5.4469(3)Å b=15.8455(10)Å c=18.2412(9)Å
α=90° β=90° γ=90°
Methyl 5-chloro-4-hydroxy-2,2-dioxo-1<i>H</i>-2λ^6^,1-benzothiazine-3-carboxylate
C10H8ClNO5S
Acta Crystallographica Section E (2020) 76, 10 1657-1660
a=11.153(3)Å b=6.8926(15)Å c=14.600(3)Å
α=90° β=97.528(5)° γ=90°
Methyl 4-amino-2-oxo-1,2-dihydroquinoline-3-carboxylate
C11H10N2O3
Acta Crystallographica Section E (2003) 59, 4 o412-o414
a=10.033(2)Å b=7.27(2)Å c=13.538(3)Å
α=90.00° β=90.64(2)° γ=90.00°
1-ethyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid
C12H11NO4
Acta Crystallographica Section E (2002) 58, 3 o254-o256
a=9.278(2)Å b=14.050(4)Å c=8.938(2)Å
α=90.00° β=111.21(3)° γ=90.00°
1-Allyl-4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carboxylic acid
C13H15NO4
Acta Crystallographica Section E (2005) 61, 6 o1833-o1835
a=16.823(4)Å b=7.179(2)Å c=19.847(5)Å
α=90.00° β=90.00° γ=90.00°
Methyl 1-acetonyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate
C14H13NO5
Acta Crystallographica Section E (2005) 61, 12 o4180-o4182
a=11.084(4)Å b=15.120(5)Å c=8.133(3)Å
α=90.00° β=109.77(3)° γ=90.00°
4-(4-ethoxyphenylamino)-2-oxo-1,2-dihydroquinoline
C17H16N2O2
Acta Crystallographica Section E (2001) 57, 8 o721-o722
a=7.075(3)Å b=8.783(5)Å c=12.469(5)Å
α=105.85(4)° β=93.44(3)° γ=106.89(3)°
N-(1-Adamantyl)-4-hydroxy-2-(2-methylpropyl)-2-oxo-1,2-dihydroquinoline-3- carboxamide
C24H30N2O3,0.5C3H8O1
Acta Crystallographica Section E (2001) 57, 5 o414-o415
a=15.140(4)Å b=13.655(3)Å c=12.286(3)Å
α=90.00° β=110.51(3)° γ=90.00°
Ethyl 4-butylamino-2-chloroquinoline-3-carboxylate
C16H19ClN2O2
Acta Crystallographica Section E (2001) 57, 3 o254-o255
a=8.174(2)Å b=8.760(2)Å c=11.793(2)Å
α=75.68(2)° β=85.77(2)° γ=84.98(2)°
C11H11NO2
C11H11NO2
Acta Crystallographica Section E (2004) 60, 12 o2356-o2358
a=7.8474(12)Å b=8.4660(14)Å c=14.033(3)Å
α=90° β=90° γ=90°
2-Bromomethyl-<i>N</i>-isopropyl-7,8-dimethoxy-1,2-dihydro-1,3- oxazolo[3,2-<i>a</i>]quinoline-4-carboxamide
C18H21BrN2O5
Acta Crystallographica Section E (2008) 64, 6 o1031
a=8.736(2)Å b=9.968(2)Å c=10.588(3)Å
α=86.90(2)° β=80.90(2)° γ=80.04(2)°
Ethyl 4-(2-amino-1-cyano-2-oxoethyl)-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylate
C18H19N3O4
Acta Crystallographica Section E (2006) 62, 12 o5386-o5387
a=8.2279(15)Å b=10.555(2)Å c=11.701(3)Å
α=116.092(15)° β=94.213(16)° γ=104.475(15)°
4-Hydroxy-1-methyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid(4-oxo-2-propyl-4H-quinazolin-3-yl)-amide
C22H20N4O4
Acta Crystallographica Section C (2000) 56, 4 e168-e169
a=12.474(3)Å b=15.213(4)Å c=10.684(3)Å
α=90.00° β=105.95(3)° γ=90.00°
Ethyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)acetate
C14H15NO4
Acta Crystallographica Section E (2009) 65, 5 o968
a=21.608(2)Å b=9.2155(9)Å c=14.6795(12)Å
α=90.00° β=119.632(9)° γ=90.00°
Ethyl 5-[(1<i>H</i>-benzoimidazol-2-yl)aminocarbonyl]-4-hydroxy-2-methyl-6-oxo-\ 1-propyl-1,6-dihydropyridine-3-carboxylate—–ethanol—–methanol (4/2/1)
4(C20H22N4O5),2(C2H6O),CH4O
Acta Crystallographica Section E (2009) 65, 8 o1984
a=10.5527(4)Å b=13.9720(4)Å c=16.0242(5)Å
α=86.804(3)° β=70.980(3)° γ=78.652(3)°
Methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)acetate
C13H13NO4
Acta Crystallographica Section E (2010) 66, 12 o3195
a=9.0792(6)Å b=11.4904(6)Å c=11.4071(7)Å
α=90.00° β=105.272(7)° γ=90.00°
(<i>RS</i>)-2-Oxo-4-(1-phenylethylamino)-1,2-dihydroquinoline-3-carboxylic acid
C18H16N2O3
Acta Crystallographica Section E (2011) 67, 11 o3054
a=14.612(2)Å b=5.9750(6)Å c=18.014(2)Å
α=90.00° β=110.814(14)° γ=90.00°
Methyl 1-allyl-4-hydroxy-2,2-dioxo-1<i>H</i>-2λ^6^,1-benzothiazine-3-carboxylate
C13H13NO5S
Acta Crystallographica Section E (2013) 69, 11 o1698
a=17.8654(12)Å b=6.9444(5)Å c=21.1462(16)Å
α=90.00° β=90.122(7)° γ=90.00°
6-Ethoxycarbonyl-5,7-dihydroxy-2,3-dihydro-1<i>H</i>- pyrido[3,2,1-<i>ij</i>]quinolinium tribromide
C15H16NO4,Br3
Acta Crystallographica Section E (2013) 69, 1 o82
a=7.6491(8)Å b=9.1729(10)Å c=13.3722(14)Å
α=102.355(9)° β=98.777(9)° γ=98.093(9)°
(<i>R</i>,<i>S</i>)-2'-Amino-6'-methyl-2,5',5'-trioxo-6'<i>H</i>-spiro[indoline-3,4'-pyrano[3,2-<i>c</i>][2,1]benzothiazine]-3'-carbonitrile dimethylformamide monosolvate
C20H14N4O4S,C3H7NO
Acta Crystallographica Section E (2014) 70, 7 o786-o787
a=17.2493(12)Å b=9.6046(5)Å c=27.7664(17)Å
α=90.00° β=90.00° γ=90.00°
6-Hydroxy-1,2-dihydro-4<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinolin-4-one
C11H9NO2
Acta Crystallographica Section E (2013) 69, 3 o340
a=7.9987(3)Å b=7.6297(2)Å c=14.3500(4)Å
α=90.00° β=101.386(3)° γ=90.00°